Boston Scientific’s Irish ops pulled down $1.4B last year | Wall Street Beat Wall Street Beat

Boston Scientific (NYSE:BSX) posted pre-tax profits of $1.4 billion from its Irish unit and other foreign subsidiaries last year, according to the Irish Times.

Marlborough, Mass.-based medical device company Boston Scientific is 1 of the Emerald Isle’s largest employers, with a 4,500-employee workforce there.

BSX’s Irish operations reported revenues of $5.37 billion for the 12 months ended Dec. 31, according to the newspaper, up 2% compared with 2011. The pre-tax profit increase represents 272% growth over the prior year, the Times reported.

Sign up to get our free newsletters delivered straight to your inbox

BSX logged a net loss of $725 million, or 52¢ per share, on sales of $1.74 billion for the 3 months ended Sept. 30. That represents a 7.4% top-line slide. Adjusted EPS were 16¢, just topping the 15¢ consensus on Wall Street.

 PE owner seeks $10B for Bausch & Lomb
The private equity owner of Bausch & Lomb is looking to sell the eye-care giant for $10 billion, according to BusinessWeek.

Warburg Pincus tapped Goldman Sachs to broker the deal, according to the magazine, citing "2 two people with knowledge of the matter."

Warburg Pincus bought the Rochester, N.Y.-based company for $3.7 billion in September 2007 after a damaging recall of 1 of its contact lens solutions.

Sanofi (NYSE:SNY), GlaxoSmithKline (NYSE:GSK) and Merck (NYSE:MRK) are said to be in the running, with others including Abbott (NYSE:ABT) waiting in the wings.

Rumors surfaced over the summer that Warburg might seek to take B&L public. That could still happen if a private buyer can’t be found, according to BusinessWeek.
Read more

 Harvard Bioscience gains 15% on subsidiary’s spinout
Harvard Bioscience shares are up more than 15% today after the company announced the planned spinout of its Harvard Apparatus Regenerative Technology unit.

HBIO shares were trading at $4.34 apiece as of about 1:50 p.m. today, up 14.6%.
Read more

 sBioMed seeks $5M in private placement

SBioMed, the sterilization product maker led by former Stryker CEO Stephen MacMillan, is seeking to raise $5 million in a private placement, MacMillan told in an email.

MacMillan said the placement includes "many" current investors and "strong interest" from other backers in the medical industry.

"The opportunities in front of us are almost endless, from both a product and market perspective, so a clear short-term goal is prioritizing sales and product development needs. The near-term sales opportunities are very large just within hospital and healthcare facilities generally, but we’re also seeing a big opportunity within pharmaceutical and clean room manufacturing, as Steriplex is stronger and much ‘greener’ and less toxic than currently available products. A sporicidal disinfectant without [volatile organic compounds] is a clear winner," he told us.

 Funding Roundup

 Analysts’ ups and downs

  • Abbott (NYSE:ABT): JP Morgan reiterates “neutral” rating, $72 price target; Morgan Stanley reiterates "equal-weight" rating.
  • Align Technology (NSDQ:ALGN): Goldman Sachs initiates coverage at “neutral” rating, $28 price target.
  • Baxter (NYSE:BAX): Leerink Swann reiterates "outperform" rating, $74 price target.
  • Cynosure (NSDQ:CYNO): Leerink Swann maintains "outperform" rating, $31 price target.
  • Edwards Lifesciences (NYSE:EW): Leerink Swann reiterates “outperform” rating, $100 price target.
  • Hill-Rom (NYSE:HRC): Goldman Sachs upgrades from “neutral” to “buy” rating, raises price target from $30 to $39.
  • Hospira (NYSE:HSP): Goldman Sachs downgrades from “neutral” to “sell” rating.
  • Intuitive Surgical (NSDQ:ISRG): Cantor Fitzgerald maintains “hold” rating, raises price target from $475 to $525.
  • NuVasive Inc. (NSDQ:NUVA): Leerink Swann maintains "market perform" rating, $16 price target.
  • Smith & Nephew (FTSE:SN, NYSE:SNN): Investec raises from “hold” to “buy” rating.
  • Spectranetics (NSDQ:SPNC): Benchmark Co. reiterates "buy" rating, $7 price target.
  • Stryker (NYSE:SYK): Bank of America Merrill Lynch reiterates "buy" rating, raises price target from $57 to $67; Goldman Sachs raises from "neutral" to "buy" rating, raises price target from $55 to $68.
  • Teleflex (NYSE:TFX): Leerink Swann maintains "market perform" rating, ~$72 price target.
  • Varian Medical (NYSE:VAR): Cantor Fitzgerald reiterates "hold" rating, raises price target from $63 to $70.
  • Volcano (NSDQ:VOLC): Credit Suisse Group downgrades from "outperform" to "neutral" rating, lowers price target from $32 to $27; Leerink Swann reiterates "outperform" rating, $32 price target.
  • Zimmer (NYSE:ZMH): Goldman Sachs upgrades from “sell” to “neutral” rating, raises price target from $58 to $70.

RSS From Medical Design & Outsourcing

  • GlobTek presents its latest level VI AC/DC adapter and connverter
    T-43086-WWVV-X.X-Q Model is an addition to GlobTek’s Level VI compliant GT-43086 family and represents GlobTek’s 6 Watt wall plug-in series of AC/DC adapters (power supplies and chargers) with International Interchangeable blades. GlobTek’s changeable input blade system with individual field replaceable input plugs, including: North America and Japan NEMA 1-15P, Australian, UK BS 1363, European CEE […]
  • Sanmina’s familiarity with FDA gets skin treatment product to market fast
    The medical market for cosmetic devices is booming. However, quickly launching new products to meet demand is becoming more challenging because device manufactures face increased regulatory scrutiny. To help meet regulatory requirements, aesthetic and other medical-device OEMs are partnering with electronics manufacturing services (EMS) companies that also offer expertise with the FDA filings necessary to […]
  • Fluid connectors and quick disconnects for IVD equipment from CPC
    Colder Products Company (CPC) offers thousands of tubing connectors, quick disconnects and fittings for smart fluid handling in IVD and analytical equipment. Non-spill connectors speed testing throughput by eliminating drips, preventing air inclusion and increasing operator safety. Panel mount connectors can be added to existing equipment or bottle caps to provide secure, leak-free connections. Puncture […]
  • 310 Watt desktop medical power supply meets efficiency level VI requirements
    Power Partners releases a new 310 Watt medical grade desktop power supply from their PEAMD Series of AC and DC adapters. The 310 Watt unit is packed for ideal performance inside a compact case measuring 7.8 x 4 x 2 in. with a weight of only 3 lbs. The PEAMD310 Series is approved to the latest […]
  • Saelig introduces Multiple Instrument System MIS4 universal test system
    Saelig Company has introduced the ABI Electronics’ Multiple Instrument Station MIS4, an all-in-one testing tool that provides all commonly required test instruments in one compact programmable hardware module, mounted in a compact case or installed in a PC-drive bay. Controlled by ABI’s sophisticated SYSTEM 8 Ultimate PC software with a simple yet programmable operator interface, […]
  • AssurX announces document management software update for small to mid-size companies in FDA regulated industries
    AssurX, an enterprise quality management, risk and regulatory compliance solution provider, announces the release of the latest update to their AssurX document management software. The document management solution provides a cost-effective solution for small to medium sized companies faced with streamlined operations and is fully compliant for FDA regulated industries. Ideal solution for small to […]
  • Saelig presents new Amplicon Impact-R 1100F series computer
    Saelig Company announces the Amplicon Impact-R 1100F series, a fanless system powered by the Intel ATOM D2550 processor. Configured with a high performance 2.5 in. MLC Solid State Drive (SSD), the Impact-R 1100F series is a silent controller system. With options for multiple serial communication ports, the Impact-R 1100F can offer up seven DB9 connections […]
  • Gerresheimer to acquire Centor
    Gerresheimer AG, a partner to the global pharmacy and healthcare industry, will further extend its pharmaceutical packaging business with the acquisition of Centor. Gerresheimer has reached an agreement with Nemera Development S.A. to acquire 100% of the share capital of Centor US Holding. “Centor is the highly profitable market leader for plastic vials and closures in […]
  • Methods Machine Tools presents the new Nakamura-Tome NTRX-300
    Methods Machine Tools, a developer of precision machine tools and automation, has introduced the new Nakamura-Tome NTRX-300, a multitasking turning center featuring complete parts machining in one operation, with a built-in load and unload automation system and advanced operator recognition management software. The NTRX-300 features true opposing twin spindles: an 8 in. A2-6 25 HP or […]
  • MSC Apex Diamond Python and Smart Midsurface speeds modeling to validation
    MSC Software announced a new release of MSC Apex, the company’s award-winning next generation Computer Aided Engineering (CAE) platform. The MSC Apex Diamond Python release introduces: · The fourth release of MSC Apex Modeler is a CAE Specific direct modeling and meshing solution that streamlines CAD clean-up, simplification and meshing workflow. New in this release is […]
  • Quality Metrics: FDA’s plan for a key set of measurements to help ensure manufacturers are producing quality medications
    Editor’s Note: This article is written by Ashley Boam and Mary Malarkey from the “FDA Voice” blog. Boam is an FDA’s acting Director of the Office of Policy for Pharmaceutical Quality, the Office of Pharmaceutical Quality and the Center for Drug Evaluation and Research. Malarkey is an FDA’s Director if the Office of Compliance and Biologics Quality […]

Leave a Reply